Pacific Biosciences Of California | PACB - Debt


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Pacific Biosciences Of California

Pacific Biosciences Of California reported $896.84M in Debt for its fiscal quarter ending in March of 2023.


Debt Change
Accelerate Diagnostics AXDX:US USD 75.84M 677K
Agilent A:US USD 2.73B 238M
Bruker BRKR:US USD 1.23B 9.9M
Danaher DHR:US USD 19.83B 155M
General Electric GE:US USD 22.42B 9.93B
Illumina ILMN:US USD 2.24B 499M
NanoString Technologies NSTG:US USD 227M 379K
Pacific Biosciences Of California PACB:US USD 896.84M 156K
PerkinElmer PKI:US USD 4.36B 33.87M
Quidel QDEL:US USD 2.59B 51.2M
Roche Holding ROG:VX CHF 25.35B 2.4B
Standard Biotools Inc FLDM:US USD 65.07M 175K
Thermo Fisher Scientific TMO:US USD 35.26B 769M
Waters WAT:US USD 1.48B 94.71M